Vivet Therapeutics

📍 Paris, France🗓 Founded 2016👥 31 employees💰 Last funded May 2018
Biotechnology Research🌐 vivet-therapeutics.com
Website LinkedIn
Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. Vivet Therapeutics is focused on optimizing gene therapy through collaborating with the Fundacion para la Investigacion Medica Aplicada (CIMA, Universidad de Navarra) to develop new AAV vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in Vivet Therapeutics?
Vivet Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Vivet Therapeutics last raise funding?
The most recent investment in Vivet Therapeutics recorded on gritt.io was in May 2018.
When was Vivet Therapeutics founded?
Vivet Therapeutics was founded in 2016.
What industry is Vivet Therapeutics in?
Vivet Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Vivet Therapeutics based?
Vivet Therapeutics is headquartered in Paris, France.